Stellar Biotechnologies

About:

Stellar Biotechnologies develops treatments for dermatological and anorectal diseases

Website: http://stellarklh.com/

Top Investors: Pharmascience, Inveready, Lumira Ventures

Description:

Stellar Biotechnologies, Inc. is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccine pipelines (targeting cancers, immune disorders, Alzheimer's and inflammatory diseases) and for assessing immune system function. KLH can also be used in immunotoxicology studies for monitoring the immunomodulatory effects of drug candidates.